IL6 and type 2 diabetes mellitus: Supporting this, a large genetic study by Georgakis et al. (358,554 individuals) linked downregulated IL-6 signaling to lower risks of ischemic heart disease, abdominal aortic aneurysm, type 2 diabetes, and better cardiometabolic profiles [122].